Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions
- 4 June 2012
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 22 (2) , 111-121
Abstract
Purpose: When medications are modified in response to changing clinical conditions, confounding by indication arises that cannot be controlled using traditional adjustment. Inverse probability of treatment weights (IPTWs) can address this confounding given assumptions of no unmeasured confounders and that all patients have a positive probability of receiving all levels of treatment (positivity). We sought to explore these assumptions empirically in the context of epoetin‐alfa (EPO) dosing and mortality.Methods: We developed a single set of IPTWs for seven EPO dose categories and evaluated achieved covariate balance, mortality hazard ratios, and confidence intervals using two levels of treatment model parameterization and weight deletion.Results: We found that IPTWs improved covariate balance for most confounders, but was not optimal for prior hemoglobin. Including more predictors in the treatment model or retaining highly weighted individuals resulted in estimates closer to the null, although precision decreased.Conclusion: We chose to evaluate weights and covariate balance at a single time‐point to facilitate an empirical analysis of model assumptions. These same assumptions are applicable to a time‐dependent analysis, although empirical examination is not straight forward in that case. We find that the inclusion of rare treatment decisions and the high weights that result is needed for covariate balance under the positivity assumption. Removal of these influential weights can result in bias in either direction relative to the original confounding. It is therefore important to determine the reason for these rare patterns and whether inference is possible for all treatment levels. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution--A Simulation StudyAmerican Journal of Epidemiology, 2010
- Relationship between Epoetin Alfa Dose and MortalityClinical Journal of the American Society of Nephrology, 2010
- Hemoglobin Level Variability: Anemia Management among Variability GroupsAmerican Journal of Nephrology, 2009
- Parenteral Iron UseClinical Journal of the American Society of Nephrology, 2009
- Effect of Epoetin Alfa Dose Changes on Hemoglobin and Mortality in Hemodialysis Patients with Hemoglobin Levels Persistently below 11 g/dLClinical Journal of the American Society of Nephrology, 2009
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment RegimensThe International Journal of Biostatistics, 2005
- Epoetin Alfa Use in Patients With ESRD: An Analysis of Recent US Prescribing Patterns and Hemoglobin OutcomesAmerican Journal of Kidney Diseases, 2005
- Analytic Strategies to Adjust Confounding using Exposure Propensity Scores and Disease Risk Scores: Nonsteroidal Antiinflammatory Drugs and Short-term Mortality in the ElderlyAmerican Journal of Epidemiology, 2005
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989